Literature DB >> 32272199

COVID-19 is not just a flu. Learn from Italy and act now.

Andrea De Giorgio1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32272199      PMCID: PMC7136886          DOI: 10.1016/j.tmaid.2020.101655

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN: 1477-8939            Impact factor:   6.211


× No keyword cloud information.
It is important not to underestimate the small opponents: you can see an elephant, a little mosquito, but not a virus. Dear reader, wherever you are reading, do not understimate the novel coronavirus named SARS-CoV-2. You especially know the name of the disease, COVID-19, but names are not so important. This novel coronavirus is traveling very fast and will arrive soon in your country. I do not want to thoroughgoing statistical analysis, but I want sensitize you about this novel coronavirus. Some information about SARS-CoV-2: the average incubation period is still unclear because of significant variation among patients, ranging from around 3.6 days [1] to around 6.4 days [2]. Symptoms of infection include fever, chills, cough, coryza, sore throat, breathing difficulty, myalgia, nausea, vomiting, diarrhea [3], and older people with medical comorbidities is demonstrated having a poorer prognosis [3]. SARS-CoV-2 infection can lead to cardiac injury, respiratory failure, acute respiratory distress syndrome, and death [4]; infections by this virus continue to rise as do the number of deaths as confirmed by World Health Organization (WHO) that has also recently announced COVID-19 outbreak a pandemic [5], and in Italy the situation has become tragic. The patient 1 (it was not possible to find patient 0) was discovered on 20th February when a 38-year-old man from the city of Codogno had showed up at the hospital. Since 20th February two large clusters of outbreaks have spread first in the Northern Italy, later all over the country. The virus is spreading very quickly and efficiently and to date numbers about outbreak are very worrying with dramatically increasing within a few weeks: 86,498 total cases (F = 42,8%; M = 57,2%), 66,414 positive people, 9134 fatalities and 10,950 recoveries. To date, the number of total cases from Italy's outbreak exceeds those in China (data are updated to 27th March). Median age of positive cases is 62 years old; median age of fatalities is 80,5 years old; median age of healthcare professionals (HPs) positive cases is 49 years old. Lethality is controversial, probably overestimate due to the fact that there is high number of positive undiagnosed cases. Among the dead there are also very young: 18 between 30 and 39 years old (0,2% of the total), 72 between 40 and 49 years old (0,9% of the total). Most of the dead ranging from 80 to 89 years old, 3010 (39,7% of the total). Almost all of them with pre-existing cardiovascular disease, lung disease, psychiatric conditions, cancer, diabetes and obesity. It has been reported a case of one young man, was 33, without any pre-existing disease (all data are updated to 27th March) [6]. A dramatic situation is the one in which patients die alone in hospital and their relatives are unable to visit or see them for the last time, but they will be able to see them only in a coffin. Currently, the most affected area is Bergamo (and its province) where we had to witness dramatic scenes, such as the one in which coffins were taken to the crematorium by army vehicles because hearses were no longer available: too many deaths. Cases are multiplying and our National healthcare service is collapsing. Many regions are increasing intensive care beds, revolutionizing entire hospital wards. Our HPs are facing COVID-19 pulling 12-h shifts in critical situations with minimal to non-existent personal protective equipments (PPEs). It is utter nonsense not to protect adequately the HPs, for their safety firstly and secondly because this can increase the outbreak. Indeed, lacking PPEs led both many HPs to become COVID-19 positive (7,145), and to the death of several doctors (51; about 9% of the total cases; all data are updated to 27th March) [6]. Since March 11th Italy's government has gradually implemented increasingly restrictive measures, now very severe, extraordinary and profound. De facto almost all of Italy is in lockdown: closure of schools, university, and many business such as theaters, cinemas, pubs, and so on, blanket public transportation restrictions, quarantine zone in all country, sporting events, all religious ceremonies (also funerals and weddings) are suspended. Public parks have even been closed. There are few exceptions such as post offices, pharmacies, and markets/malls that can remain open also during weekend. However, we are a democracy, and Italian Constitution guarantees the freedom of people, so it is very difficult for the Italian government to take stricter measures. On March 26th, the governor of the Lombardy Region, the region most affected by the virus and which sees the number of positive cases increasing, said: “I am worried, I do not know if we missed something”. Moreover, the Italian Prime Minister has recently announced that lockdown will continues until April 13th. In these days, in Europe, especially France, Spain, United Kingdom and Germany are facing a situation of increasing infection. In particular, videos from Spain have showed patients lying in the hospital corridors, highlighting that the country has not been able to cope with the wave of infection: in just one day there were ten thousand more positive cases. Italy has proved extraordinary in its reorganization and it is astonishing how our lesson and our sacrifice is not useful to others. On the other side of the world the situation can still be contained, but the United States, for example, seems to have acted late to contain the outbreak: 100,392 (update to 27th March). The situation in our country seems to highlight that we have acted too late, despite the extraordinary effort of our National healthcare service. However, in the next days we will have a real picture of the situation, but from Italy a cry is raising: this virus is not a normal influenza. Please, do not wait any longer to take drastic measures to contain the outbreak. Do it now!

Funding source

No financial support has been received.

Declaration of competing interest

The author declares that there are no conflicts of interest regarding the publication of this paper.
  4 in total

1.  Similarity in Case Fatality Rates (CFR) of COVID-19/SARS-COV-2 in Italy and China.

Authors:  Rossella Porcheddu; Caterina Serra; David Kelvin; Nikki Kelvin; Salvatore Rubino
Journal:  J Infect Dev Ctries       Date:  2020-02-29       Impact factor: 0.968

2.  Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea.

Authors:  Moran Ki
Journal:  Epidemiol Health       Date:  2020-02-09

3.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.

Authors:  Nanshan Chen; Min Zhou; Xuan Dong; Jieming Qu; Fengyun Gong; Yang Han; Yang Qiu; Jingli Wang; Ying Liu; Yuan Wei; Jia'an Xia; Ting Yu; Xinxin Zhang; Li Zhang
Journal:  Lancet       Date:  2020-01-30       Impact factor: 79.321

Review 4.  Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures.

Authors:  Yixuan Wang; Yuyi Wang; Yan Chen; Qingsong Qin
Journal:  J Med Virol       Date:  2020-03-29       Impact factor: 20.693

  4 in total
  8 in total

1.  COVID-19-Related Laboratory Analyte Changes and the Relationship Between SARS-CoV-2 and HIV, TB, and HbA1c in South Africa.

Authors:  R Hesse; D J van der Westhuizen; J A George
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Changes in the spatial distribution of COVID-19 incidence in Italy using GIS-based maps.

Authors:  Cecilia Acuti Martellucci; Ranjit Sah; Ali A Rabaan; Kuldeep Dhama; Cristina Casalone; Kovy Arteaga-Livias; Toyoaki Sawano; Akihiko Ozaki; Divya Bhandari; Asaka Higuchi; Yasuhiro Kotera; Zareena Fathah; Namrata Roy; Mohammed Ateeq Ur Rahman; Tetsuya Tanimoto; Alfonso J Rodriguez-Morales
Journal:  Ann Clin Microbiol Antimicrob       Date:  2020-07-18       Impact factor: 3.944

Review 3.  Lessons from the coronavirus disease 2019 (COVID-19) pandemic response in China, Italy, and the U.S.: a guide for Africa and low- and middle-income countries.

Authors:  Yanjie Zhang; Isaac Iyinoluwa Olufadewa; Miracle Ayomikun Adesina; Marlene Davis Ekpo; Seyi John Akinloye; Temiloluwa Ololade Iyanda; Pamela Nwachukwu; Lalit Dzifa Kodzo
Journal:  Glob Health J       Date:  2021-02-09

4.  Clinical outcome before and after COVID-19 quarantine in patients affect of knee and hip osteoarthritis.

Authors:  Marco Mattia Larghi; Miriam Grassi; Faugno Luca; Emanuele Placenza; Corrado Rampulla; Alfonso Manzotti
Journal:  Acta Biomed       Date:  2020-11-10

5.  Navigating a Pandemic: A Qualitative Study of Knowledge, Sources of Information, and COVID-19-Related Precautions Taken by HBCU Students.

Authors:  Jeannette Wade; Stephanie Teixeira Poit; Anna Lee; Sally Ryman; Dextiny McCain; Christopher Doss; Smriti Shrestha; Adrienne Aiken Morgan
Journal:  J Racial Ethn Health Disparities       Date:  2022-01-15

6.  Trust in Science as a Possible Mediator between Different Antecedents and COVID-19 Booster Vaccination Intention: An Integration of Health Belief Model (HBM) and Theory of Planned Behavior (TPB).

Authors:  Massimiliano Barattucci; Stefano Pagliaro; Chiara Ballone; Manuel Teresi; Carlo Consoli; Alice Garofalo; Andrea De Giorgio; Tiziana Ramaci
Journal:  Vaccines (Basel)       Date:  2022-07-08

7.  The scientific literature on Coronaviruses, COVID-19 and its associated safety-related research dimensions: A scientometric analysis and scoping review.

Authors:  Milad Haghani; Michiel C J Bliemer; Floris Goerlandt; Jie Li
Journal:  Saf Sci       Date:  2020-05-07       Impact factor: 6.392

8.  Willingness to Receive COVID-19 Booster Vaccine: Associations between Green-Pass, Social Media Information, Anti-Vax Beliefs, and Emotional Balance.

Authors:  Andrea De Giorgio; Goran Kuvačić; Dražen Maleš; Ignazio Vecchio; Cristina Tornali; Wadih Ishac; Tiziana Ramaci; Massimiliano Barattucci; Boris Milavić
Journal:  Vaccines (Basel)       Date:  2022-03-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.